WHO ICTRP trial
Which of two drugs, steroid or tofacitinib, is better in giving quick relief in…
CTRI/2025/10/096003 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/10/096003 |
|---|---|
| Public title | Which of two drugs, steroid or tofacitinib, is better in giving quick relief in arthritis pain? |
| Scientific title | Tofacitinib versus oral glucocorticoids as bridge therapy in rheumatoid arthritis- a randomized controlled trial - TOBRA |
| Primary sponsor | Post Graduate Institute of Medical Education and Research Chandigarh |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified |
| Interventions | Intervention1: Tofacitinib: Oral tofacitinib 5 mg twice daily for 8 weeks Control Intervention1: Oral prednisolone: Oral prednisolone in a predetermined tapering regimen [10 mg once daily (week 1-2), 7.5 mg once daily (week 3-4), 5 mg once… |
| Registration date | Oct 13, 2025 |
| Target size | 120 |
| Secondary IDs | Nil |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: